Indaptus Therapeutics INDP
NASDAQ INDP
$3.24 +0.28 (+9.46%)
As of: Oct 21, 2026 · 3:29 PM EDT

Indaptus Therapeutics (INDP) Total Debt (2025)

Updated

Indaptus Therapeutics (INDP) reported Total Debt of $6.5 million for Q2 2025.

Analysis

Indaptus Therapeutics (INDP) Total Debt (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,137.85 Bn 1,106.43 Bn 19.71 Bn 54.91 Bn
2 Johnson & Johnson 618.85 Bn 537.37 Bn 17.26 Bn 49.04 Bn
3 AbbVie 503.03 Bn 476.14 Bn 12.70 Bn 70.82 Bn
4 Merck 368.52 Bn 322.90 Bn 12.21 Bn 53.91 Bn
5 Novartis Ag 298.19 Bn 262.18 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 261.33 Bn 235.02 Bn 12.86 Bn 32.35 Bn
7 Amgen 237.14 Bn 192.53 Bn 7.24 Bn 57.30 Bn
8 Gilead Sciences 191.35 Bn 165.54 Bn 6.22 Bn 26.25 Bn
9 Pfizer 169.80 Bn 116.45 Bn 10.94 Bn 63.19 Bn
10 Indaptus Therapeutics 207.72 Mn 180.34 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 6.50 Mn
API Access

Indaptus Therapeutics Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=INDP&period=max&api_key=YOUR_API_KEY